Home / Brands / Deva Holding AS - Cerkezkoy Subesi
Deva Holding AS - Cerkezkoy Subesi Recalls
6 recalls on record · July 31, 2019 to July 31, 2019 · Drugs
July 31, 2019DrugsFDA
Deva Holding AS - Cerkezkoy Subesi recalls Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul
Hazard: CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
July 31, 2019DrugsFDA
Deva Holding AS - Cerkezkoy Subesi recalls Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-count bottle (NDC 67877-541-14),
Hazard: CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
July 31, 2019DrugsFDA
Deva Holding AS - Cerkezkoy Subesi recalls Temozolomide Capsules, 140 mg, packaged in a) 5-count bottle (NDC 67877-540-07), b) 14-count bottle (NDC 67877-540-14),
Hazard: CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
July 31, 2019DrugsFDA
Deva Holding AS - Cerkezkoy Subesi recalls Temozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877-539-14),
Hazard: CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
July 31, 2019DrugsFDA
Deva Holding AS - Cerkezkoy Subesi recalls Temozolomide Capsules, 20 mg, packaged in a) 5-count bottle (NDC 67877-538-07), b) 14-count bottle (NDC 67877-538-14), R
Hazard: CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
July 31, 2019DrugsFDA
Deva Holding AS - Cerkezkoy Subesi recalls Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 67877-537-07), b) 14-count bottle (NDC 67877-537-14), Rx
Hazard: CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.